Video Challenge
The Challenge
2023 Awards
2022 Awards
2021 Awards
2020 Awards
2019 Awards
2018 Awards
2017 Awards
2016 Awards
2015 Awards
2014 Awards

2019 RCSB PDB Video Challenge for High School Students

Mechanisms of Bacterial Resistance
to Beta-lactam Antibiotics


2018 Video Challenge

Winners | Entries | Judges | Overview | Learning Resources

Note: Videos are intended for communication and not rigorous scientific review.

Congratulations to the 2018 Winners:

Judge's Award First Place
Beta-Lactam Resistance: The Pandemic of Tomorrow

By Chelsea Okocha, Serena Wang, and Angela Song of West Windsor-Plainsboro High School South, West Windsor, NJ
Team Advisor: Karel Marshall

Judge's Award Second Place
Toby the Superbug: Origin Story

By Chris Boodram, Michelle Li, and Leia Park of Stuyvesant High School, New York, NY
Team Advisor: Gilbert Papagayo

Judge's Award Third Place
Resistance to Beta-lactam Antibiotics in Bacteria

By Vanessa Lu, William Dang, Ethan Du, and Jason Le of Mira Mesa High School, San Diego, CA
Team Advisor: Lisa Yoneda

Viewer's Choice Award
The Beta-lactam Antibiotic Crisis

By Sohil Dharia and Michael Dicpinigaitis of Jericho High School, Jericho, NY
Team Advisor: Michael Giallorenzo

2018 Challenge Details

In this challenge, students were asked to tell a story that communicates 2 things:

  1. To use relevant 3D protein structures, to teach the viewers about the molecular changes that occur in bacteria that help them to become resistant to beta-lactam antibiotics. Videos were expected to include a general introduction to the action of antibiotics, and describe an aspect of one of the topics related to resistance, such as:
    • Beta-lactamases and resistance
    • Superbugs: New Delhi beta-lactamase and MRSA
    • How scientists are modifying beta-lactam antibiotics to fight resistance
  2. To make the viewer aware of the dangerously high level of antibiotic resistance caused by misuse and overuse of antibiotics, and to explain to them how they might be affected by it, and what they can do prevent it.

The section below was avialable to the participants as introduction to the topic, and offred links to relevant 3D structures and additional resources.

2018 Challenge Dates

The video submission opened on March 6, 2018 and concluded on May 23, 2018. Award winners were announced at on June 12, 2017.

2018 Learning Resources

I. Introduction

Antibiotics are small molecules, originally discovered as defensive molecules made by fungi and other organisms, and now created by medical scientists. They bind to essential bacterial molecules, such as enzymes and ribosomes, blocking the growth of the bacteria or killing them. Because these bacterial proteins are structurally different from their animal equivalents or are non-existent in them, they cause no harm to the organism treated for bacterial infection.

Figure 1 presents main classes of antibiotics and their target protein/molecule organized by the biochemical process that they interrupt in bacteria. In this video challenge, we will be focusing only on the action of and resistance to the beta-lactam class.

Figure 1

Main classes of antibiotics and their target protein/molecule organized by the biochemical process that they interrupt in bacteria. Download as PDF

II. How beta-lactam antibiotics work

Bacteria protect themselves from osmotic pressure by building multiple layers of peptidoglycans. By the way the peptidoglycans are organized, we can distinguish between 2 types of bacteria: Gram-positive and Gram-negative. Gram-positive bacteria build a thick glycan lattice on the outside of the lipid bilayer membrane, while the Gram-negative bacteria build a thinner layer of peptidoglycan sheets in between 2 lipid bilayer membranes (Figure 2a ). Peptidoglycan monomers are synthesized in the bacterial cytosol and each consists of two sugars connected to a short chain of amino acids ending with two D-alanines. The peptide has also a pentaglycine bridge extending to the side (Figure 2b).

Once synthesized, the monomers are moved across the cell membrane where they are inserted into the existing peptidoglycan sheet. First, the sugars are assembled into chains, which are then crosslinked via the pentaglycine bridges. These processes are catalyzed by enzymes called penicillin-binding proteins (PBPs). Most of them have a DD-transpeptidase domain that is responsible for the crosslinking of peptidoglycans using a reactive serine residue in the active site (Figure 2c). The serine cleaves the terminal D-alanine and connects the penultimate D-alanine to the pentaglycine bridge of another glycan (Figure 2d).

Figure 2

Figure 2a: Schematic view of outer membrane arrangement in Gram-positive (left) and Gram-negative (right) bacteria.

Figure 2b: Peptidoglycan monomer in schematic representation (left) and in space filling representation (right).

Figure 2c: Penicillin binding protein (PBP) with DD-transpeptidase domain and reactive serine residue highlighted. PDB structure 5hl9

Figure 2d: PBP creating a link between two peptidoglycan chains. PDB structure: 5hl9

The penicillin binding proteins, as the name suggests, have high affinity to bind penicillin and other beta-lactam antibiotics. The name beta-lactam antibiotics is derived from the core part of their chemical structure, the beta-lactam ring (Figure 3a). Beta-lactam antibiotics bind covalently to the active serine reside in the PBPs (Figure 3b), interrupting the crosslinking process and leaving the bacteria with an incomplete cell wall. As a result, bacteria become permeated with water and eventually explode.

Figure 3

Figure 3a: Penicillin antibiotic in schematic representation (left) and ball-and-stick representation (right) with the beta-lactam ring highlighted in yellow.

Figure 3b: Ampicillin binding covalently to PBP. PDB structure 5hl9

Table 1: Major groups of beta-lactam antibiotics


III. Mechanisms of bacterial resistance

In the face of overuse and misuse of antibiotics, new strains of bacteria have emerged that can proliferate even in the presence of the newest antibiotics. The resistance to beta-lactam antibiotics is possible due to 2 mechanisms:

  1. Inactivation by a bacterial enzyme, beta-lactamase

    Beta-lactamases are enzymes expressed by resistant bacteria that can cleave the beta-lactam ring in antibiotics rendering them ineffective. In the presence of beta-lactamases, PBPs can continue their cross-linking activity and bacteria can thrive (Figure 4a).

    Depending on the sequence similarity, the beta lactamases are divided into classes A, B, C, and D. Class A, C, and D have a reactive serine in the active site, while class B has a zinc ions in the active site (Figure 4b).

  2. Alteration to the target site

    Bacteria can develop mutations in the PBPs drug binding site that are of no consequence to their crosslinking activity, but render them immune to antibiotics action. The Methicillin-resistant Staphylococcus aureus (MRSA) is an example of bacteria that developed this type of resistance.

Figure 4

Figure 4a: Beta-lactamase (5uj3, class A) destroying the antibiotic cefotaxime (cephalosporin).

Figure 4b: NDM-1 (green) is a class B beta-lactamase. It recognizes the key reactive portion of the antibiotics using two zinc ions (shown in magenta), but largely ignores the rest of the molecule. In that way, it can disable nearly all beta-lactam antibiotics (PDB entry 4eyl).

Table 2: Mechanisms of bacterial resistance

There are 2 ways in which the resistance genes can be passed on:

  • Via Chromosome: the gene is transferred from generation to generation (vertical transfer)
  • Via Plasmid: passed from bacterial species to species (horizontal transfer)

IV. Fighting the resistance mechanisms

Researchers design inhibitors of beta-lactamases that can be given along with beta-lactam antibiotics. They inhibit the beta-lactamases leaving the antibiotic free to bind to PBPs.

Table 3: Competitive inhibitors for beta-lactamases

Visualization Resources

  1. The user guide for NGL can be found here. The NGL is the default 3D viewer accessible from each structure summary page, from the tab “3D View”.
  2. You can download and open these sessions using UCSF Chimera. Use the tutorials available here and here to edit the sessions, create animations or save pictures.
    Color coding for PBPs sessions: DD-transpeptidase domain is highlighted in darker orange, the reactive serine residue is highlighted in dark red, antibiotic bound has carbons highlighted in green.
    Color coding for beta-lactamases sessions: reactive serine residue is highlighted in red (classes A, C, D), zinc (class B) in purple, antibiotic (or inhibitor in the active site) has carbons highlighted in green.



  • Sung Joon Kim et al. (2015) Peptidoglycan Architecture of Gram-positive Bacteria by Solid-State NMR. Biochim Biophys Acta. 1848(0): 350–362.
  • Dustin T. King et al. (2017) Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B. The Journal of Biological Chemistry 292: 979-993.
  • Wenlin Lee et al. (2001) A 1.2-Å snapshot of the final step of bacterial cell wall biosynthesis. PNAS 98 (4): 1427-1431